Health Professional Radio - Podcast

Bryan Witherbee, CEO of Adarza Biosystems discusses ZIVA™, a label-free protein detection platform that can accurately test 100s of protein from a single drop of blood in a time and cost-efficient manner. While the initial launch of ZIVA was focused on biomarker detection in cancer, they have changed direction to assist in vaccine development and immunosurveillance following COVID-19 and they are now applying this technology in the quantification of SARS-CoV-2/COVID-19 antibodies and other upper respiratory pathogens.